Life Science Industry Needs Insurance Security

Growth in biotechnology and other life sciences industries is spurring initial public offerings and merger and acquisition activity that expands companies’ risk exposure, insurance executives said.

Their views were aired last week when Willis North America, a unit of London-headquartered insurance brokerage firm Willis Group Holdings, sponsored a Web seminar examining the insurance needs such corporations should consider to protect their growing assets.